We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
202 hedge funds and large institutions have $473M invested in Sana Biotechnology in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 67 increasing their positions, 57 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
275% more call options, than puts
Call options by funds: $2.17M | Put options by funds: $577K
20% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 25
18% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 57
1.49% more ownership
Funds ownership: 60.02% → 61.51% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less funds holding
Funds holding: 203 → 202 (-1)
27% less capital invested
Capital invested by funds: $651M → $473M (-$179M)
Holders
202
Holders Change
-1
Holders Change %
-0.49%
% of All Funds
2.49%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
67
Reduced
57
Closed
25
Calls
$2.17M
Puts
$577K
Net Calls
+$1.59M
Net Calls Change
-$807K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$9.78M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$6.93M |
| 3 |
Goldman Sachs
New York
|
+$6.67M |
| 4 |
Millennium Management
New York
|
+$3.81M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.27M |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.85M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.54M |
| 3 |
Corient Private Wealth
Miami,
Florida
|
-$2.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.2M |
| 5 |
Jane Street
New York
|
-$2.11M |
